Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharmalex Nordic ApS
APS
Active
CVR 37541540
Lyngby Hovedgade 10C, 2800
Kongens Lyngby
Activities of holding companies
·
NACE 6421
Est. 2016 · 10 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Activities of holding companies
/
Pharmalex Nordic ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
2M
3M
5M
3M
2021
3M
2022
3M
2023
4M
2024
4M
2025
EBITDA
DKK millions
3M
1M
0M
-1M
-3M
0M
2021
0M
0%
2022
0M
0%
2023
-2M
-200%
2024
2M
+200%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
3.352
3.283
2.786
4.083
3.534
Staff expenses
-3.148
-2.967
-3.021
-6.330
-1.870
EBITDA
204
315
-235
-2.247
1.664
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
204
315
-235
-2.247
1.664
Net financials
4.512
105
4.555
-88.680
-499
Profit before tax
4.716
421
4.321
-90.927
1.165
Tax
-221
-984
-1.919
-2.480
-545
Net profit
4.937
1.405
6.239
-88.448
1.710
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
58.917
276.311
273.510
195.381
202.869
Equity
33.136
34.541
40.780
-47.667
-45.958
Long-term debt
20.945
182.885
223.926
230.061
246.043
Short-term debt
4.836
40.293
8.804
12.988
2.784
Total debt
25.780
223.179
232.730
243.049
248.827
Financial ratios
5-year trend
EBITDA margin (of gross profit)
47.1%
This company
2021
2025
Equity ratio
-22.7%
This company
38.2%
Market median
-159% vs market
2021
2025
Return on equity
170969100.0%
This company
18.4%
Market median
+929179791% vs market
2021
2025
Net profit margin (of gross profit)
48.4%
This company
2021
2025
Asset turnover (of gross profit)
0.02×
This company
2021
2025
Debt / equity
5.41×
This company
0.62×
Market median
-773% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pharmalex Nordic ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
